Código 292119 (Harmonized System 2012 by 6 digits)
2024: US$44.9M, Total Trade Exchange
2024: US$16M, International Sales
2024: US$28.9M, International Purchases
In 2024, the trade exchange (includes international purchases and sales) of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) was US$44.9M.
In 2024, the main commercial destinations of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were Guatemala (US$19.5k), Panama (US$5.75k), Brazil (US$1.93k), El Salvador (US$712), and Argentina (US$508).
The main commercial origins of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) in 2024 were United States (US$6.98M), China (US$6.74M), Germany (US$4.8M), Japan (US$1.84M), and Philippines (US$1.79M).
In the global context, the main exporting countries of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) in 2022 were China (US$632M), Germany (US$242M), and United States (US$189M). In the same year, the main importing countries of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were United States (US$220M), Germany (US$133M), and South Korea (US$105M).
US$44.9M, Total Trade Exchange (2024)
In 2024, the total trade exchange of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) in Mexico (including international purchases and sales) was US$44.9M.
The visualizations show the net balance of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
June, 2026
In June 2026, international sales of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were US$1.69M, while international purchases reached US$3.21M. The above results in a trade balance of -US$1.52M.
2026-Q2: US$2.27M, International Sales
The visualization shows the quarterly concentration of international sales of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) at state level.
In the second quarter of 2026, international sales were US$2.27M, being the states with the most sales Estado de México (US$2.27M).
Guatemala: US$19.5k, Main commercial destination (2024)
In 2024, the countries with the most international purchases from Mexico were Guatemala (US$19.5k), Panama (US$5.75k), Brazil (US$1.93k), El Salvador (US$712), and Argentina (US$508).
United States: US$6.98M, Main Commercial Origin (2024)
The countries with the most international sales to Mexico in 2024 were United States (US$6.98M), China (US$6.74M), Germany (US$4.8M), Japan (US$1.84M), and Philippines (US$1.79M).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts). In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were China (US$632M), Germany (US$242M), and United States (US$189M). In the same year, the main importing countries for Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were United States (US$220M), Germany (US$133M), and South Korea (US$105M).